IN8bio (INAB) Revenue & Revenue Breakdown
IN8bio Revenue Highlights
IN8bio Revenue by Period
IN8bio Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | - |
IN8bio Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $3.75M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | - |
IN8bio Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
WVE | Wave Life Sciences | $113.31M | $19.69M |
CUE | Cue Biopharma | $5.49M | $1.72M |
TFFP | TFF Pharmaceuticals | $733.87K | $650.22K |
LIFE | aTyr Pharma | $353.00K | $235.00K |
PALI | Palisade Bio | $250.00K | - |
ANIX | Anixa Biosciences | $210.00K | - |
GANX | Gain Therapeutics | $55.18K | - |
GRCL | Gracell Bio | - | - |
RVPH | Reviva Pharmaceuticals | - | - |
CNSP | CNS Pharmaceuticals | - | - |
ZURA | Zura Bio | - | - |
INAB | IN8bio | - | - |
ANNX | Annexon | - | - |
PYPD | PolyPid | - | - |
CFRX | ContraFect | - | - |
LTRN | Lantern Pharma | - | - |
ALLR | Allarity Therapeutics | - | - |
WINT | Windtree Therapeutics | - | - |
INMB | INmune Bio | $-155.00K | - |
INAB Revenue FAQ
What is IN8bio’s yearly revenue?
IN8bio's yearly revenue for 2023 was $0, representing an increase of 100.00% compared to 2022. The company's yearly revenue for 2022 was $0, representing an increase of 100.00% compared to 2021. INAB's yearly revenue for 2021 was $0, representing an increase of 100.00% compared to 2020.
What is IN8bio’s quarterly revenue?
IN8bio's quarterly revenue for Q2 2024 was $0, a 100.00% increase from the previous quarter (Q1 2024), and a 0% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). INAB's quarterly revenue for Q4 2023 was $3.75M, a 100.00% increase from the previous quarter (Q3 2023), and a 0% increase year-over-year (Q4 2022).
What is IN8bio’s revenue growth rate?
IN8bio's revenue growth rate for the last 3 years (2021-2023) was 0%, and for the last 5 years (2019-2023) was 0%.